Pages with the fewest revisions

Jump to navigation Jump to search

Showing below up to 250 results in range #251 to #500.

View (previous 250 | next 250) (20 | 50 | 100 | 250 | 500)

  1. Non-homologous end joining‏‎ (1 revision)
  2. ICRP Publication 68‏‎ (1 revision)
  3. Optimisation of protection‏‎ (1 revision)
  4. ICRP Publication 82‏‎ (1 revision)
  5. Excess absolute risk‏‎ (1 revision)
  6. Exposure pathway‏‎ (1 revision)
  7. Quasi-threshold dose‏‎ (1 revision)
  8. Functional subunits‏‎ (1 revision)
  9. Activity median aerodynamic diameter‏‎ (1 revision)
  10. Ground-level enhancement‏‎ (1 revision)
  11. Radon progeny‏‎ (1 revision)
  12. Reference parameter value‏‎ (1 revision)
  13. ICRP Publication 101a‏‎ (1 revision)
  14. ICRP Publication 114‏‎ (1 revision)
  15. ICRP Publication 129‏‎ (1 revision)
  16. ICRP Publication 143‏‎ (1 revision)
  17. Compartment (environmental)‏‎ (1 revision)
  18. Specific absorbed fraction‏‎ (1 revision)
  19. ICRP Publication 19‏‎ (1 revision)
  20. Surface contamination‏‎ (1 revision)
  21. ICRP Publication 30 (Part 2)‏‎ (1 revision)
  22. ICRP Publication 4‏‎ (1 revision)
  23. Translocation‏‎ (1 revision)
  24. Multistage carcinogenesis model‏‎ (1 revision)
  25. ICRP Publication 54‏‎ (1 revision)
  26. ICRP Publication 69‏‎ (1 revision)
  27. ICRP Publication 83‏‎ (1 revision)
  28. Phantom‏‎ (1 revision)
  29. Ras‏‎ (1 revision)
  30. Homologous recombination‏‎ (1 revision)
  31. Authorised discharge‏‎ (1 revision)
  32. Reference phantom‏‎ (1 revision)
  33. ICRP Publication 101b‏‎ (1 revision)
  34. ICRP Publication 90‏‎ (1 revision)
  35. ICRP Publication 115‏‎ (1 revision)
  36. ICRP Publication 13‏‎ (1 revision)
  37. Clinical audit‏‎ (1 revision)
  38. Size-specific dose estimate‏‎ (1 revision)
  39. ICRP Publication 144‏‎ (1 revision)
  40. ICRP Publication 2‏‎ (1 revision)
  41. ICRP Publication 30 (Part 3)‏‎ (1 revision)
  42. Derived consideration reference level‏‎ (1 revision)
  43. Threshold level‏‎ (1 revision)
  44. ICRP Publication 40‏‎ (1 revision)
  45. ICRP Publication 55‏‎ (1 revision)
  46. Dose conversion convention‏‎ (1 revision)
  47. ICRP Publication 7‏‎ (1 revision)
  48. Organ at risk‏‎ (1 revision)
  49. ICRP Publication 84‏‎ (1 revision)
  50. Exclusion‏‎ (1 revision)
  51. Principles of protection‏‎ (1 revision)
  52. Radiation-induced second cancer‏‎ (1 revision)
  53. Acute exposure‏‎ (1 revision)
  54. Allometry‏‎ (1 revision)
  55. Rb‏‎ (1 revision)
  56. Reference value‏‎ (1 revision)
  57. ICRP Publication 102‏‎ (1 revision)
  58. ICRP Publication 91‏‎ (1 revision)
  59. ICRP Publication 116‏‎ (1 revision)
  60. ICRP Publication 130‏‎ (1 revision)
  61. Slice‏‎ (1 revision)
  62. ICRP Publication 145‏‎ (1 revision)
  63. Spongiosa‏‎ (1 revision)
  64. ICRP Publication 20‏‎ (1 revision)
  65. ICRP Publication 30 (Part 4)‏‎ (1 revision)
  66. Derived investigation level‏‎ (1 revision)
  67. Marrow cellularity‏‎ (1 revision)
  68. ICRP Publication 41‏‎ (1 revision)
  69. Directional dose equivalent‏‎ (1 revision)
  70. Multitarget equation‏‎ (1 revision)
  71. ICRP Publication 56‏‎ (1 revision)
  72. Dose conversion factor‏‎ (1 revision)
  73. ICRP Publication 70‏‎ (1 revision)
  74. Effect modifier‏‎ (1 revision)
  75. ICRP Publication 85‏‎ (1 revision)
  76. Endosteum‏‎ (1 revision)
  77. Pilomatricoma‏‎ (1 revision)
  78. Radiation-induced secondary malignancy‏‎ (1 revision)
  79. Radiological attack‏‎ (1 revision)
  80. Reactive oxygen species‏‎ (1 revision)
  81. Reference worker‏‎ (1 revision)
  82. Biological half-life‏‎ (1 revision)
  83. ICRP Publication 92‏‎ (1 revision)
  84. ICRP Publication 117‏‎ (1 revision)
  85. ICRP Publication 131‏‎ (1 revision)
  86. Informed consent‏‎ (1 revision)
  87. ICRP Publication 146‏‎ (1 revision)
  88. Concentration ratio‏‎ (1 revision)
  89. ICRP Publication 21‏‎ (1 revision)
  90. System of radiological protection‏‎ (1 revision)
  91. ICRP Publication 30 (Supplement A to Part 3)‏‎ (1 revision)
  92. Derived limit‏‎ (1 revision)
  93. Time-resolved computed tomography‏‎ (1 revision)
  94. ICRP Publication 42‏‎ (1 revision)
  95. Mutation component‏‎ (1 revision)
  96. ICRP Publication 57‏‎ (1 revision)
  97. Waste management‏‎ (1 revision)
  98. Normal tissue complication probability‏‎ (1 revision)
  99. ICRP Publication 71‏‎ (1 revision)
  100. ICRP Publication 86‏‎ (1 revision)
  101. Radiological controlled area‏‎ (1 revision)
  102. Human Alimentary Tract Model‏‎ (1 revision)
  103. Referrer‏‎ (1 revision)
  104. ICRP Publication 104‏‎ (1 revision)
  105. Biomarker‏‎ (1 revision)
  106. ICRP Publication 93‏‎ (1 revision)
  107. ICRU 4-element tissue‏‎ (1 revision)
  108. ICRP Publication 132‏‎ (1 revision)
  109. Clonogenic surviving fraction‏‎ (1 revision)
  110. ICRP Publication 147‏‎ (1 revision)
  111. Cone beam computed tomography‏‎ (1 revision)
  112. ICRP Publication 22‏‎ (1 revision)
  113. ICRP Publication 30 (Supplement B to Part 3)‏‎ (1 revision)
  114. Derived reference level‏‎ (1 revision)
  115. ICRP Publication 43‏‎ (1 revision)
  116. Disposal facility‏‎ (1 revision)
  117. Treatment preparation in radiotherapy‏‎ (1 revision)
  118. ICRP Publication 58‏‎ (1 revision)
  119. Notification value‏‎ (1 revision)
  120. ICRP Publication 72‏‎ (1 revision)
  121. Other (systemic) tissues‏‎ (1 revision)
  122. ICRP Publication 87‏‎ (1 revision)
  123. Absorption Type‏‎ (1 revision - redirect page)
  124. Additional dose‏‎ (1 revision)
  125. Ambient dose equivalent‏‎ (1 revision)
  126. Human Respiratory Tract Model‏‎ (1 revision)
  127. Automatic exposure control‏‎ (1 revision)
  128. Region‏‎ (1 revision)
  129. ICRP Publication 105‏‎ (1 revision)
  130. ICRP Publication 94‏‎ (1 revision)
  131. ICRP Publication 119‏‎ (1 revision)
  132. ICRU sphere‏‎ (1 revision)
  133. ICRP Publication 133‏‎ (1 revision)
  134. ICRP Publication 148‏‎ (1 revision)
  135. Stakeholder‏‎ (2 revisions)
  136. Tachycardia‏‎ (2 revisions)
  137. Tissue equivalent material‏‎ (2 revisions)
  138. Myocardial stress test‏‎ (2 revisions)
  139. Effective dose equivalent‏‎ (2 revisions)
  140. Oversight‏‎ (2 revisions)
  141. Existing exposure situation‏‎ (2 revisions)
  142. Projected dose‏‎ (2 revisions)
  143. Gastroschisis‏‎ (2 revisions)
  144. Radionuclides of natural origin‏‎ (2 revisions)
  145. Angiogenesis‏‎ (2 revisions)
  146. Recovery (cellular or tissue)‏‎ (2 revisions)
  147. Hyperbaric oxygen‏‎ (2 revisions)
  148. Bioturbation‏‎ (2 revisions)
  149. Retrievability‏‎ (2 revisions)
  150. Cardioverter-defibrillator‏‎ (2 revisions)
  151. Immune system‏‎ (2 revisions)
  152. Institutional control‏‎ (2 revisions)
  153. Consequential late effects‏‎ (2 revisions)
  154. DRL value‏‎ (2 revisions)
  155. Worker‏‎ (2 revisions)
  156. Nuclear track detectors‏‎ (2 revisions)
  157. Epithelium‏‎ (2 revisions)
  158. Acceptance test‏‎ (2 revisions)
  159. Radiation safety officer‏‎ (2 revisions)
  160. Gastrulation‏‎ (2 revisions)
  161. Radioresponsiveness‏‎ (2 revisions)
  162. Habitual mouth breather‏‎ (2 revisions)
  163. Annihilation photons‏‎ (2 revisions)
  164. Recovery responder‏‎ (2 revisions)
  165. Hyperfractionation‏‎ (2 revisions)
  166. Bone marrow‏‎ (2 revisions)
  167. Reversibility‏‎ (2 revisions)
  168. In vivo radiobioassay‏‎ (2 revisions)
  169. Cohort study‏‎ (2 revisions)
  170. Solar particle event‏‎ (2 revisions)
  171. Containment‏‎ (2 revisions)
  172. Target tissue‏‎ (2 revisions)
  173. Measuring and Reducing Radon Levels in your Home‏‎ (2 revisions)
  174. Dose-length product‏‎ (2 revisions)
  175. Working level‏‎ (2 revisions)
  176. OLINDA/EXM‏‎ (2 revisions)
  177. Particle radiance‏‎ (2 revisions)
  178. Equieffective dose‏‎ (2 revisions)
  179. Expanded and aligned radiation field‏‎ (2 revisions)
  180. Protection strategy‏‎ (2 revisions)
  181. Radiation source‏‎ (2 revisions)
  182. Adventitious‏‎ (2 revisions)
  183. Radiosensitiser‏‎ (2 revisions)
  184. Habitual nose breather‏‎ (2 revisions)
  185. Hypertrophic cardiomyopathy‏‎ (2 revisions)
  186. Background dose (rate)‏‎ (2 revisions)
  187. Rehabilitation of living conditions‏‎ (2 revisions)
  188. Right to know‏‎ (2 revisions)
  189. Incidence‏‎ (2 revisions)
  190. Solar wind‏‎ (2 revisions)
  191. Stenosis‏‎ (2 revisions)
  192. Local DRL‏‎ (2 revisions)
  193. Detriment‏‎ (2 revisions)
  194. Tolerability‏‎ (2 revisions)
  195. Medical exposure‏‎ (2 revisions)
  196. Dose-rate effect‏‎ (2 revisions)
  197. Naturally occurring radioactive material‏‎ (2 revisions)
  198. Working level month‏‎ (2 revisions)
  199. Electron-capture decay‏‎ (2 revisions)
  200. Fluoroscopically or computed tomography guided interventions‏‎ (2 revisions)
  201. Radiosensitivity, cellular‏‎ (2 revisions)
  202. Hypoplasia‏‎ (2 revisions)
  203. Backscatter detection system‏‎ (2 revisions)
  204. Bradycardia‏‎ (2 revisions)
  205. Rigidity‏‎ (2 revisions)
  206. Security‏‎ (2 revisions)
  207. Incident‏‎ (2 revisions)
  208. Intermediate level waste‏‎ (2 revisions)
  209. Coronary heart disease‏‎ (2 revisions)
  210. LD 50/30‏‎ (2 revisions)
  211. Decay constant‏‎ (2 revisions)
  212. Telangiectasia‏‎ (2 revisions)
  213. Member of the public‏‎ (2 revisions)
  214. Unattached fraction‏‎ (2 revisions)
  215. Necrosis‏‎ (2 revisions)
  216. Dose of record Hp (10)‏‎ (2 revisions)
  217. Electrophysiology‏‎ (2 revisions)
  218. Patient entrance reference point‏‎ (2 revisions)
  219. Potential recoverability correction factor‏‎ (2 revisions)
  220. Protective action guide‏‎ (2 revisions)
  221. Accreditation‏‎ (2 revisions)
  222. Radiation worker‏‎ (2 revisions)
  223. Genomic integrity‏‎ (2 revisions)
  224. Hazard‏‎ (2 revisions)
  225. Bragg peak‏‎ (2 revisions)
  226. Inclusiveness‏‎ (2 revisions)
  227. Source-related‏‎ (2 revisions)
  228. Internal conversion electron‏‎ (2 revisions)
  229. Cosmic Radiation in Aviation‏‎ (2 revisions)
  230. Storage‏‎ (2 revisions)
  231. Decommissioning‏‎ (2 revisions)
  232. Track structure‏‎ (2 revisions)
  233. Mendelian diseases‏‎ (2 revisions)
  234. Dose-threshold‏‎ (2 revisions)
  235. Neurological syndrome‏‎ (2 revisions)
  236. Occupational exposure‏‎ (2 revisions)
  237. Peak skin dose‏‎ (2 revisions)
  238. Fractional absorption in the gastrointestinal tract‏‎ (2 revisions)
  239. Action Level‏‎ (2 revisions)
  240. Radioactive dispersion device‏‎ (2 revisions)
  241. Radon: Units of Measure‏‎ (2 revisions)
  242. Health Surveillance‏‎ (2 revisions)
  243. Reference air kerma‏‎ (2 revisions)
  244. Basal cell‏‎ (2 revisions)
  245. Branching fraction‏‎ (2 revisions)
  246. Chronic exposure‏‎ (2 revisions)
  247. Self-help protection‏‎ (2 revisions)
  248. Individual-related‏‎ (2 revisions)
  249. Colony‏‎ (2 revisions)
  250. Subcutaneous tissue‏‎ (2 revisions)

View (previous 250 | next 250) (20 | 50 | 100 | 250 | 500)

Retrieved from "http://icrpaedia.org/Special:FewestRevisions"